Howe & Rusling’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
Howe & Rusling's SYNH Position: Q4 2022 in Review
Howe & Rusling sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 157 shares — an estimated $7K sold.
Howe & Rusling first reported a position in SYNH in Q4 2016 and held it in 24 quarters. The position peaked at $109K in Q2 2017. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.
- Howe & Rusling reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
- Howe & Rusling sold 157 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $7K.
- Howe & Rusling first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2016 and held it in 24 quarters.
- Howe & Rusling's Syneos Health, Inc. Class A Common Stock position peaked at $109K in Q2 2017.
- 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.
Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.